Tamper-resistant transdermal dosage form comprising an active agent componenet and an adverse agent component at the distal site of the active agent layer

Details for Australian Patent Application No. 2004235794 (hide)

International Classifications

Event Publications

27 October 2005 PCT application entered the National Phase

PCT publication WO2004/098567 Priority application(s): WO2004/098567

4 June 2009 Application Accepted

Published as AU-B-2004235794

23 July 2009 Corrigenda

Applications Accepted - Name Index Under the name Purdue Pharma L.P., Application No. 2004235794, under INID (54) correct the title to read Tamperresistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.